更好的 GLP-1 投資選擇：禮來 (Eli Lilly) 還是 Viking Therapeutics？
· finance.yahoo.com
目前這還稱不上是競爭對手。
Demand for GLP-1 drugs is soaring. Thanks to recent breakthroughs, medicines in this category are expanding their addressable markets and treating conditions su...